MOLECULAR STUDY OF CALR GENE: MYELOPROLIFERATIVE NEOPLASMS (MPN) WITH NEGATIVE PHILADELPHIA AND JAK2/V617F

被引：0

作者：

Culurgioni, F. ^{[1
]}

Musiu, C. ^{[1
]}

Uda, S. ^{[1
]}

Benziane, A. ^{[1
]}

Pettinau, M. ^{[1
]}

Usala, E. ^{[1
]}

Cabras, M. G. ^{[1
]}

机构：

[1] Ctr Trapianti Midollo Osseo PO A Businco Ao Brotz, Unita Operat Ematol, Cagliari, Italy

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PU039

引用

页码：167 / 168

页数：2

共 50 条

[31] ACTIVATED STAT5 AS NOVEL STEM TARGET IN JAK2 V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS (MPN) [J].

Hadzijusufovic, E. ;

Keller, A. ;

Schur, F. ;

Cerny-Reiterer, S. ;

Hoermann, G. ;

Mayerhofer, M. ;

Boudot, C. ;

Gouilleux, F. ;

Muellauer, L. ;

Moriggl, R. ;

Valent, P. .

HAEMATOLOGICA, 2015, 100 :524-525

[32] JAK2 V617F mutation in philadelphia chromosome-positive myeloproliferative disease [J].

Yun, Hyeong-Kee ;

Shin, Myung-Geun ;

Moon, Chang-Jin ;

Kim, Hye-Ran ;

Lee, Sun-Young ;

Kim, Hyeoung-Joon ;

Cho, Duck ;

Shin, Jong-Hee ;

Suh, Soon-Pal ;

Ryang, Dong-Wook .

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 :112-112

[33] THROMBOTIC RISK ASSOCIATED WITH JAK2 V617F MUTATION AND INHERITED OR ACQUIRED THROMBOPHILIA IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS [J].

Rossi, E. ;

Betti, S. ;

Za, T. ;

Ciminello, A. ;

Fresa, A. ;

Bartolomei, F. ;

Di Giovanni, A. ;

Chiusolo, P. ;

De Stefano, V. .

HAEMATOLOGICA, 2017, 102 :97-97

[34] A study of JAK2 (V617F) gene mutation in patients with chronic myeloproliferative disorders [J].

Hamidah, N. H. ;

Farisah, N. R. ;

Azlinda, A. B. ;

Wong, F. L. ;

Das, S. ;

Fadillah, S. A. W. ;

Ainoon, O. .

CLINICA TERAPEUTICA, 2012, 163 (02) :109-113

[35] Prevalence of JAK2V617F, CALR in Philadelphia Positive and Negative Myeloproliferative Neoplasm [J].

Abedi, Elham ;

Karimi, Mehran ;

Cohan, Nader ;

Haghpanah, Sezaneh ;

Yaghobi, Ramin ;

Azarpira, Negar ;

Moghadam, Mohamad ;

Bayat, Elahe ;

Farokhian, Farnoush ;

Mohammadi, Hamid ;

Lak, Elahe Razmara ;

Golafshan, Habib Allah ;

Ramzi, Mani .

GALEN MEDICAL JOURNAL, 2021, 10

[36] JAK2 V617F mutation detection in chronic myeloproliferative neoplasms by digital PCR [J].

Waterhouse, M. ;

Pfeifer, D. ;

Follo, M. ;

Bertz, H. ;

Finke, J. .

ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 :196-196

[37] Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients [J].

Macedo, Luciana Conci ;

Quintero, Fernanda de Cesare ;

Pagliari-E-Silva, Sara ;

Barbosa Pagnano, Katia Borgia ;

Rodrigues, Camila ;

de Alencar, Josiane Bazzo ;

Sell, Ana Maria ;

Laguila Visentainer, Jeane Eliete .

BLOOD CELLS MOLECULES AND DISEASES, 2016, 57 :54-57

[38] JAK-STAT PATHWAY IN MYELOPROLIFERATIVE NEOPLASMS: FROM JAK2 V617F TO CALRETICULIN MUTANTS [J].

Constantinescu, S. N. .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 :31-31

[39] Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms [J].

Kim, Hye-Ran ;

Choi, Hyun-Jung ;

Kim, Yeo-Kyeoung ;

Kim, Hyeoung-Joon ;

Shin, Jong-Hee ;

Suh, Soon-Pal ;

Ryang, Dong-Wook ;

Shin, Myung-Geun .

PLOS ONE, 2013, 8 (01)

[40] Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cells [J].

Cheng, Zhiyong ;

Fu, Jianzhu ;

Liu, Guimin ;

Zhang, Lijun ;

Xu, Qian ;

Wang, Su-yun .

LEUKEMIA & LYMPHOMA, 2018, 59 (01) :196-203

← 1 2 3 4 5 →